| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.40▼ | 1.41▼ | 1.42▼ | 1.28▲ | 1.62▼ |
| MA10 | 1.41▼ | 1.41▼ | 1.37▲ | 1.35▲ | 1.92▼ |
| MA20 | 1.42▼ | 1.35▲ | 1.33▲ | 1.60▼ | 5.07▼ |
| MA50 | 1.37▲ | 1.28▲ | 1.33▲ | 2.04▼ | 10.43▼ |
| MA100 | 1.33▲ | 1.49▼ | 1.66▼ | 5.68▼ | 16.24▼ |
| MA200 | 1.46▼ | 1.84▼ | 2.08▼ | 9.75▼ | 4,090.27▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | 0.004▲ | 0.017▲ | 0.042▲ | 0.121▲ |
| RSI | 49.815▼ | 56.167▲ | 57.063▲ | 33.585▼ | 23.765▼ |
| STOCH | 25.000 | 65.370 | 84.405▲ | 25.205 | 4.228▼ |
| WILL %R | -75.000▼ | -30.000 | -28.571 | -61.538 | -98.643▼ |
| CCI | -106.488▼ | 32.340 | 60.906 | -27.281 | -63.622 |
|
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
Tuesday, August 04, 2026 06:00 AM
Dienogest is first-line therapy for pelvic pain associate with endometriosis The endometriosis treatment market is projected to reach $5.2 billion by 2034 FORT LAUDERDALE, FL / ACCESS Newswire / ...
|
|
Tuesday, August 04, 2026 05:30 AM
Pharmaceutical firm Sunshine Biopharma Inc. (NASDAQ:SBFM) on Tuesday said it received regulatory approval to introduce its 2mg generic Dienogest tablets to the Canadian market. The significant ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/08/26 | 1.36 | 1.4651 | 1.32 | 1.40 | 252,423 |
| 05/08/26 | 1.33 | 1.39 | 1.22 | 1.33 | 253,205 |
| 04/08/26 | 1.23 | 1.52 | 1.16 | 1.31 | 2,365,362 |
| 03/08/26 | 1.15 | 1.2087 | 1.12 | 1.17 | 77,587 |
| 31/07/26 | 1.24 | 1.24 | 1.16 | 1.17 | 77,702 |
| 30/07/26 | 1.33 | 1.34 | 1.10 | 1.23 | 1,224,353 |
| 29/07/26 | 1.43 | 1.44 | 1.23 | 1.23 | 73,187 |
| 28/07/26 | 1.53 | 1.57 | 1.41 | 1.43 | 84,504 |
| 27/07/26 | 1.69 | 1.69 | 1.44 | 1.53 | 79,908 |
| 24/07/26 | 1.76 | 1.76 | 1.66 | 1.66 | 22,710 |
|
|
||||
|
|
||||
|
|